Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H L Thomas

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Annals of Clinical Biochemistry|July 16, 2002
Laboratory analyses for poisoned patientsS H L Thomas, I D Watson
Clinical Toxicology (Philadelphia, Pa.)|September 16, 2021
Severe toxicity involving <i>N</i>-pyrrolidino etonitazene in the United Kingdom-a case reportM Pucci, S Hudson, S L Hill, et al.
Clinical Toxicology (Philadelphia, Pa.)|September 17, 2019
Synthetic cannabinoid receptor agonists: classification and nomenclatureA J Potts, C Cano, S H L Thomas, et al.
Drug Testing and Analysis|May 17, 2014
Using poisons information service data to assess the acute harms associated with novel psychoactive substancesD M Wood, S L Hill, S H L Thomas, et al.
Clinical Toxicology (Philadelphia, Pa.)|October 6, 2020
Toxicoepidemiology and predictors of death in 2,4-dinitrophenol (DNP) toxicityA J Potts, N J Bowman, D L Seger, et al.
Clinical Toxicology (Philadelphia, Pa.)|May 29, 2010
Electrocardiographic effects of methylphenidate overdoseS L Hill, R H El-Khayat, E A Sandilands, et al.
Clinical Pharmacology and Therapeutics|April 6, 2007
Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral dosesI S M Salih, R H K Thanacoody, G A McKay, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 8, 2014
Pregnancy outcome following maternal use of zanamivir or oseltamivir during the 2009 influenza A/H1N1 pandemic: a national prospective surveillance studyH J Dunstan, A C Mill, S Stephens, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 4, 2002
Thioridazine and sudden unexplained death in psychiatric in-patientsJ G Reilly, S A Ayis, I N Ferrier, et al.
Clinical Pharmacology and Therapeutics|April 27, 2007
Factors affecting drug concentrations and QT interval during thioridazine therapyR H K Thanacoody, A K Daly, J G Reilly, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Annals of Clinical Biochemistry|July 16, 2002
Laboratory analyses for poisoned patientsS H L Thomas, I D Watson
Clinical Toxicology (Philadelphia, Pa.)|September 16, 2021
Severe toxicity involving <i>N</i>-pyrrolidino etonitazene in the United Kingdom-a case reportM Pucci, S Hudson, S L Hill, et al.
Clinical Toxicology (Philadelphia, Pa.)|September 17, 2019
Synthetic cannabinoid receptor agonists: classification and nomenclatureA J Potts, C Cano, S H L Thomas, et al.
Drug Testing and Analysis|May 17, 2014
Using poisons information service data to assess the acute harms associated with novel psychoactive substancesD M Wood, S L Hill, S H L Thomas, et al.
Clinical Toxicology (Philadelphia, Pa.)|October 6, 2020
Toxicoepidemiology and predictors of death in 2,4-dinitrophenol (DNP) toxicityA J Potts, N J Bowman, D L Seger, et al.
Clinical Toxicology (Philadelphia, Pa.)|May 29, 2010
Electrocardiographic effects of methylphenidate overdoseS L Hill, R H El-Khayat, E A Sandilands, et al.
Clinical Pharmacology and Therapeutics|April 6, 2007
Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral dosesI S M Salih, R H K Thanacoody, G A McKay, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 8, 2014
Pregnancy outcome following maternal use of zanamivir or oseltamivir during the 2009 influenza A/H1N1 pandemic: a national prospective surveillance studyH J Dunstan, A C Mill, S Stephens, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 4, 2002
Thioridazine and sudden unexplained death in psychiatric in-patientsJ G Reilly, S A Ayis, I N Ferrier, et al.
Clinical Pharmacology and Therapeutics|April 27, 2007
Factors affecting drug concentrations and QT interval during thioridazine therapyR H K Thanacoody, A K Daly, J G Reilly, et al.
Pageof 3